Skip to main content
SpringerLink
Log in

FDA limits paracetamol strength to reduce overdose potential

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. New steps aimed at cutting risks from acetaminophen. FDA Consumer: 1-2, Jan 2011

  2. FDA.FDA Drug Safety Communication: prescription acetaminophen products to be limited to 325 mg per dosage unit; boxed warning will highlight potential for severe liver failure. Internet Document: [3 pages], 13 Jan 2011. Available from: URL: http://www.fda.gov

  3. FDA.FDA limits acetaminophen in prescription combination products; requires liver toxicity warnings. Internet Document: [1 page], 13 Jan 2011. Available from: URL: http://www.fda.gov

  4. Covidien.Covidien Supports FDA on Acetaminophen Safe Use. Media Release: 14 Jan 2011. Available from: URL: http://www.covidien.com

  5. Health Canada.Reminding Canadians About Using Acetaminophen Safely. Media Release: 13 Jan 2011. Available from: URL: http://www.hc-sc.ca

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

FDA limits paracetamol strength to reduce overdose potential. React. Wkly. 1335, 1 (2011). https://doi.org/10.2165/00128415-201113350-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201113350-00001

Keywords

Search

Navigation